{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:22:54Z","timestamp":1790299374237,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]},{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]},{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]},{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]},{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]},{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]},{"name":"the Estimation and Study of Total Health Expenditure in Sichuan Province","award":["No. 301021002"],"award-info":[{"award-number":["No. 301021002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-05790-3","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:11:36Z","timestamp":1741349496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An analysis of curative care expenditure for Parkinson\u2019s disease under different comorbidity conditions: an empirical study based on China"],"prefix":"10.1186","volume":"25","author":[{"given":"Yuelin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"10100","key":"5790_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"Collaborators GDaIIaP","year":"2017","unstructured":"Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"11","key":"5790_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators GPsD","year":"2018","unstructured":"Collaborators GPsD. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"issue":"10291","key":"5790_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"6","key":"5790_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5(6):525\u201335.","journal-title":"Lancet Neurol"},{"issue":"S5","key":"5790_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","volume":"255","author":"G Alves","year":"2008","unstructured":"Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP. Epidemiology of Parkinson\u2019s disease. J Neurol. 2008;255(S5):18\u201332.","journal-title":"J Neurol"},{"issue":"12","key":"5790_CR6","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1002\/mds.28762","volume":"36","author":"S Qi","year":"2021","unstructured":"Qi S, Yin P, Wang L, Qu M, Kan GL, Zhang H, et al. Prevalence of Parkinson\u2019s disease: a community-based study in China. Mov Disord. 2021;36(12):2940\u20134.","journal-title":"Mov Disord"},{"issue":"10258","key":"5790_CR7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Collaborators GDaI","year":"2020","unstructured":"Collaborators GDaI. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"5","key":"5790_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384\u20136.","journal-title":"Neurology"},{"issue":"3","key":"5790_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord. 2013;28(3):311\u20138.","journal-title":"Mov Disord"},{"key":"5790_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, et al. Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Parkinsons Dis. 2020;6:15.","journal-title":"NPJ Parkinsons Dis"},{"key":"5790_CR11","doi-asserted-by":"crossref","unstructured":"Bohingamu Mudiyanselage S, Watts JJ, Abimanyi-Ochom J, Lane L, Murphy AT, Morris ME et al. Cost of living with Parkinson\u2019s disease over 12 months in Australia: a prospective cohort study. Parkinsons Dis. 2017;2017:5932675.","DOI":"10.1155\/2017\/5932675"},{"issue":"5","key":"5790_CR12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/ane.13502","volume":"144","author":"F Hjalte","year":"2021","unstructured":"Hjalte F, Norlin JM, Kellerborg K, Odin P. Parkinson\u2019s disease in Sweden-resource use and costs by severity. Acta Neurol Scand. 2021;144(5):592\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"5790_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2169\/internalmedicine.55.4484","volume":"55","author":"A Yoritaka","year":"2016","unstructured":"Yoritaka A, Fukae J, Hatano T, Oda E, Hattori N. The direct cost of Parkinson disease at Juntendo medical university hospital, Japan. Intern Med. 2016;55(2):113\u20139.","journal-title":"Intern Med"},{"issue":"9","key":"5790_CR14","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/mds.20999","volume":"21","author":"G Wang","year":"2006","unstructured":"Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, et al. Economic burden of Parkinson\u2019s disease in a developing country: A retrospective cost analysis in Shanghai, China. Mov Disord. 2006;21(9):1439\u201343.","journal-title":"Mov Disord"},{"issue":"6","key":"5790_CR15","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.3390\/ijerph19063238","volume":"19","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhou W, Zhang D. Direct medical costs of Parkinson\u2019s disease in Southern China: a cross-sectional study based on health insurance claims data in Guangzhou City. Int J Environ Res Public Health. 2022;19(6):3238.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"5790_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000536525","volume":"58","author":"W Liu","year":"2024","unstructured":"Liu W, Nie P, Zhang J, Zhou D, Zhang J, Chen J. Clinical and economic insights into Parkinson\u2019s disease hospitalization: a comprehensive study of 19,719 inpatient cases in Hubei Province, China. Neuroepidemiology. 2024;58(4):237\u201346.","journal-title":"Neuroepidemiology"},{"key":"5790_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.parkreldis.2022.10.012","volume":"104","author":"A Hommel","year":"2022","unstructured":"Hommel A, Krijthe JH, Darweesh S, Bloem BR. The association of comorbidity with Parkinson\u2019s disease-related hospitalizations. Parkinsonism Relat Disord. 2022;104:123\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"5790_CR18","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00415-019-09360-7","volume":"266","author":"S Kasamo","year":"2019","unstructured":"Kasamo S, Takeuchi M, Ikuno M, Kawasaki Y, Tanaka S, Takahashi R, et al. Real-world pharmacological treatment patterns of patients with young-onset Parkinson\u2019s disease in Japan: a medical claims database analysis. J Neurol. 2019;266(8):1944\u201352.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"5790_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jad.2011.01.021","volume":"132","author":"NN Dissanayaka","year":"2011","unstructured":"Dissanayaka NN, Sellbach A, Silburn PA, O\u2019Sullivan JD, Marsh R, Mellick GD. Factors associated with depression in Parkinson\u2019s disease. J Affect Disord. 2011;132(1\u20132):82\u20138.","journal-title":"J Affect Disord"},{"issue":"2","key":"5790_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jamaneurol.2022.3902","volume":"80","author":"A Schrag","year":"2023","unstructured":"Schrag A, Bohlken J, Dammertz L, Teipel S, Hermann W, Akmatov MK, et al. Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease. JAMA Neurol. 2023;80(2):161\u201371.","journal-title":"JAMA Neurol"},{"issue":"4","key":"5790_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/ageing\/afaa250","volume":"50","author":"SY Yoon","year":"2021","unstructured":"Yoon SY, Shin J, Kim YW, Chang JS, Won Kim H. The mortality rate of Parkinson\u2019s disease and related comorbidities: a nationwide population-based matched cohort study in Korea. Age Ageing. 2021;50(4):1182\u20138.","journal-title":"Age Ageing"},{"issue":"1","key":"5790_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1212\/WNL.60.1.87","volume":"60","author":"JC Pressley","year":"2003","unstructured":"Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology. 2003;60(1):87\u201393.","journal-title":"Neurology"},{"issue":"12","key":"5790_CR23","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1245\/s10434-017-6079-9","volume":"24","author":"A Kahl","year":"2017","unstructured":"Kahl A, du Bois A, Harter P, Prader S, Schneider S, Heitz F, et al. Prognostic value of the age-adjusted Charlson comorbidity index (ACCI) on short- and long-term outcome in patients with advanced primary epithelial ovarian cancer. Ann Surg Oncol. 2017;24(12):3692\u20139.","journal-title":"Ann Surg Oncol"},{"key":"5790_CR24","unstructured":"Sichuan Provincial Bureau of Statistics. The 2019 Sichuan Statistical Yearbook. Accessed 25 Jan 2025. https:\/\/tjj.sc.gov.cn\/scstjj\/tjnjnew\/2020\/zk\/indexch.htm"},{"key":"5790_CR25","unstructured":"Sichuan Provincial Health Commission. The 2019 Sichuan Health Statistics Yearbook. https:\/\/wsjkw.sc.gov.cn\/scwsjkw\/njgb\/2021\/3\/15\/5dc2167777c54a8a931396c3d9b6c715.shtml Accessed 25 Jan 2025."},{"issue":"7","key":"5790_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.healthpol.2017.04.008","volume":"121","author":"M Mueller","year":"2017","unstructured":"Mueller M, Morgan D. New insights into health financing: first results of the international data collection under the system of health accounts 2011 framework. Health Policy. 2017;121(7):764\u20139.","journal-title":"Health Policy"},{"issue":"6","key":"5790_CR27","doi-asserted-by":"publisher","first-page":"e043155","DOI":"10.1136\/bmjopen-2020-043155","volume":"11","author":"H Feng","year":"2021","unstructured":"Feng H, Pan K, Li X, Zhang L, Mao L, Rui D. Case study of the beneficiary group distribution of curative care expenditure based on SHA 2011 in Xinjiang autonomous region, China. BMJ Open. 2021;11(6):e043155.","journal-title":"BMJ Open"},{"issue":"11","key":"5790_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245\u201351.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"5790_CR29","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.3802\/jgo.2019.30.e6","volume":"30","author":"V Di Donato","year":"2019","unstructured":"Di Donato V, Page Z, Bracchi C, Tomao F, Musella A, Perniola G, et al. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients. J Gynecologic Oncol. 2019;30(1):e6.","journal-title":"J Gynecologic Oncol"},{"issue":"8","key":"5790_CR30","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3390\/jcm10081751","volume":"10","author":"I Kellokumpu","year":"2021","unstructured":"Kellokumpu I, Kairaluoma M, Mecklin J-P, Kellokumpu H, V\u00e4yrynen V, Wirta E-V, et al. Impact of age and comorbidity on multimodal management and survival from colorectal cancer: a population-based study. J Clin Med. 2021;10(8):1751.","journal-title":"J Clin Med"},{"issue":"1","key":"5790_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13023-022-02524-1","volume":"17","author":"J Li","year":"2022","unstructured":"Li J, Yang L, Zhang Y, Liao H, Ma Y, Sun Q. Rare disease curative care expenditure-financing scheme-health provider-beneficiary group analysis: an empirical study in Sichuan Province, China. Orphanet J Rare Dis. 2022;17(1):373.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"5790_CR32","doi-asserted-by":"publisher","first-page":"e102149","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS ONE. 2014;9(7):e102149.","journal-title":"PLoS ONE"},{"key":"5790_CR33","doi-asserted-by":"publisher","first-page":"104135","DOI":"10.1016\/j.archger.2020.104135","volume":"90","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhou L, Liu S, Qiao Y, Wu Y, Ke C, et al. Prevalence, correlates and outcomes of multimorbidity among the middle-aged and elderly: findings from the China health and retirement longitudinal study. Arch Gerontol Geriatr. 2020;90:104135.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"5790_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41598-021-04356-8","volume":"12","author":"LL Raket","year":"2022","unstructured":"Raket LL, Oudin \u00c5str\u00f6m D, Norlin JM, Kellerborg K, Martinez-Martin P, Odin P. Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson\u2019s disease. Sci Rep. 2022;12(1):526.","journal-title":"Sci Rep"},{"issue":"2","key":"5790_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.euroneuro.2010.08.002","volume":"21","author":"S von Campenhausen","year":"2011","unstructured":"von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, et al. Costs of illness and care in Parkinson\u2019s disease: an evaluation in six countries. Eur Neuropsychopharmacol. 2011;21(2):180\u201391.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1\u20132","key":"5790_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2011.11.002","volume":"314","author":"JP Bach","year":"2012","unstructured":"Bach JP, Riedel O, Klotsche J, Spottke A, Dodel R, Wittchen HU. Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson\u2019s disease. J Neurol Sci. 2012;314(1\u20132):41\u20137.","journal-title":"J Neurol Sci"},{"issue":"1","key":"5790_CR37","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1186\/s12913-021-06908-0","volume":"21","author":"C Li","year":"2021","unstructured":"Li C, Chen Z, Khan MM. Bypassing primary care facilities: health-seeking behavior of middle age and older adults in China. BMC Health Serv Res. 2021;21(1):895.","journal-title":"BMC Health Serv Res"},{"key":"5790_CR38","doi-asserted-by":"crossref","unstructured":"Llibre-Guerra JJ, Prina M, Sosa AL, Acosta D, Jimenez-Velazquez IZ, Guerra M et al. Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: a community based study. Lancet Reg Health Am. 2022;7:None.","DOI":"10.1016\/j.lana.2021.100136"},{"issue":"13","key":"5790_CR39","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29(13):1583\u201390.","journal-title":"Mov Disord"},{"issue":"7","key":"5790_CR40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT. Parkinson\u2019s disease and parkinsonism. Am J Med. 2019;132(7):802\u20137.","journal-title":"Am J Med"},{"issue":"12","key":"5790_CR41","doi-asserted-by":"publisher","first-page":"e0243612","DOI":"10.1371\/journal.pone.0243612","volume":"15","author":"M Torti","year":"2020","unstructured":"Torti M, Fossati C, Casali M, De Pandis MF, Grassini P, Radicati FG, et al. Effect of family history, occupation and diet on the risk of Parkinson disease: a case-control study. PLoS ONE. 2020;15(12):e0243612.","journal-title":"PLoS ONE"},{"issue":"4","key":"5790_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","volume":"75","author":"GF Wooten","year":"2004","unstructured":"Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson\u2019s disease than women? J Neurol Neurosurg Psychiatry. 2004;75(4):637\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"s1","key":"5790_CR43","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8(s1):S3\u20138.","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"5790_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/mds.870130605","volume":"13","author":"A Schrag","year":"1998","unstructured":"Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson\u2019s disease revisited\u2013clinical features, natural history, and mortality. Mov Disord. 1998;13(6):885\u201394.","journal-title":"Mov Disord"},{"issue":"8","key":"5790_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/mds.28063","volume":"35","author":"J Ng","year":"2020","unstructured":"Ng J, Cort\u00e8s-Saladelafont E, Abela L, Termsarasab P, Mankad K, Sudhakar S, et al. DNAJC6 mutations disrupt dopamine homeostasis in juvenile Parkinsonism-Dystonia. Mov Disord. 2020;35(8):1357\u201368.","journal-title":"Mov Disord"},{"issue":"1","key":"5790_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/brain\/awz350","volume":"143","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M, et al. Genetic modifiers of risk and age at onset in GBA associated Parkinson\u2019s disease and lewy body dementia. Brain. 2020;143(1):234\u201348.","journal-title":"Brain"},{"issue":"6","key":"5790_CR47","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, von Coelln R, Pihlstr\u00f8m L, et al. Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov Disord. 2019;34(6):866\u201375.","journal-title":"Mov Disord"},{"issue":"7","key":"5790_CR48","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/brain\/awaa167","volume":"143","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Qin L, Pan H, Liu Z, Jiang L, He Y, et al. The role of genetics in Parkinson\u2019s disease: a large cohort study in Chinese Mainland population. Brain. 2020;143(7):2220\u201334.","journal-title":"Brain"},{"issue":"26","key":"5790_CR49","doi-asserted-by":"publisher","first-page":"6491","DOI":"10.7150\/jca.34891","volume":"10","author":"S Zang","year":"2019","unstructured":"Zang S, Zhan H, Zhou L, Wang X. Research on current curative expenditure among lung cancer patients based on the system of health accounts 2011: insights into influencing factors. J Cancer. 2019;10(26):6491\u2013501.","journal-title":"J Cancer"},{"key":"5790_CR50","doi-asserted-by":"crossref","unstructured":"Chalise HN. Healthy ageing: a basic concept. Asian J Popul Sci. 2023;2(1):124\u20138.","DOI":"10.3126\/ajps.v2i1.51096"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-05790-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-05790-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-05790-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:51:47Z","timestamp":1741351907000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-05790-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5790"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-05790-3","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of Hospital of Chengdu University of Traditional Chinese Medicine (approval no. 2020KL-001). Informed consent was obtained from all individual participants included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}